Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2002 Mar;78(917):135–141. doi: 10.1136/pmj.78.917.135

Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages

M Prince 1, M Hudson 1
PMCID: PMC1742293  PMID: 11884694

Abstract

Since liver transplantation was first performed in 1968 by Starzl et al, advances in case selection, liver surgery, anaesthetics, and immunotherapy have significantly increased the indications for and success of this operation. Liver transplantation is now a standard therapy for many end stage liver disorders as well as acute liver failure. However, while demand for cadaveric organ grafts has increased, in recent years the supply of organs has fallen. This review addresses current controversies resulting from this mismatch. In particular, methods for increasing graft availability and difficulties arising from transplantation in the context of alcohol related cirrhosis, primary liver tumours, and hepatitis C are reviewed. Together these three indications accounted for 42% of liver transplants performed for chronic liver disease in the UK in 2000. Ethical frameworks for making decisions on patients' suitability for liver transplantation have been developed in both the USA and the UK and these are also reviewed.

Full Text

The Full Text of this article is available as a PDF (156.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldo V., Floreani A., Menegon T., Grella P., Paternoster D. M., Trivello R. Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: a seroepidemiological study. Eur J Epidemiol. 2000 Jan;16(1):87–91. doi: 10.1023/a:1007600532105. [DOI] [PubMed] [Google Scholar]
  2. Belle S. H., Beringer K. C., Detre K. M. Liver transplantation for alcoholic liver disease in the United States: 1988 to 1995. Liver Transpl Surg. 1997 May;3(3):212–219. doi: 10.1002/lt.500030304. [DOI] [PubMed] [Google Scholar]
  3. Beresford T. P. Predictive factors for alcoholic relapse in the selection of alcohol-dependent persons for hepatic transplant. Liver Transpl Surg. 1997 May;3(3):280–291. doi: 10.1002/lt.500030314. [DOI] [PubMed] [Google Scholar]
  4. Bird G. L., O'Grady J. G., Harvey F. A., Calne R. Y., Williams R. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ. 1990 Jul 7;301(6742):15–17. doi: 10.1136/bmj.301.6742.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bizollon T., Ducerf C., Trepo C., Mutimer D. Hepatitis C virus recurrence after liver transplantation. Gut. 1999 Apr;44(4):575–578. doi: 10.1136/gut.44.4.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bravata D. M., Olkin I., Barnato A. E., Keeffe E. B., Owens D. K. Health-related quality of life after liver transplantation: a meta-analysis. Liver Transpl Surg. 1999 Jul;5(4):318–331. doi: 10.1002/lt.500050404. [DOI] [PubMed] [Google Scholar]
  7. Campbell D. A., Jr, Magee J. C., Punch J. D., Merion R. M., Turcotte J. G., Bromberg J. S. One center's experience with liver transplantation: alcohol use relapse over the long-term. Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S58–S64. [PubMed] [Google Scholar]
  8. Chazouilleres O., Kim M., Combs C., Ferrell L., Bacchetti P., Roberts J., Ascher N. L., Neuwald P., Wilber J., Urdea M. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 1994 Apr;106(4):994–999. doi: 10.1016/0016-5085(94)90759-5. [DOI] [PubMed] [Google Scholar]
  9. Degos F. Hepatitis C and alcohol. J Hepatol. 1999;31 (Suppl 1):113–118. doi: 10.1016/s0168-8278(99)80386-9. [DOI] [PubMed] [Google Scholar]
  10. Ferrell L. D., Wright T. L., Roberts J., Ascher N., Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology. 1992 Oct;16(4):865–876. doi: 10.1002/hep.1840160403. [DOI] [PubMed] [Google Scholar]
  11. Figueras J., Jaurrieta E., Valls C., Benasco C., Rafecas A., Xiol X., Fabregat J., Casanovas T., Torras J., Baliellas C. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology. 1997 Jun;25(6):1485–1489. doi: 10.1002/hep.510250629. [DOI] [PubMed] [Google Scholar]
  12. Frank C., Mohamed M. K., Strickland G. T., Lavanchy D., Arthur R. R., Magder L. S., El Khoby T., Abdel-Wahab Y., Aly Ohn E. S., Anwar W. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000 Mar 11;355(9207):887–891. doi: 10.1016/s0140-6736(99)06527-7. [DOI] [PubMed] [Google Scholar]
  13. Féray C., Samuel D., Gigou M., Paradis V., David M. F., Lemonnier C., Reynès M., Bismuth H. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology. 1995 Oct;22(4 Pt 1):1084–1089. [PubMed] [Google Scholar]
  14. Gane E. J., Portmann B. C., Naoumov N. V., Smith H. M., Underhill J. A., Donaldson P. T., Maertens G., Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–820. doi: 10.1056/NEJM199603283341302. [DOI] [PubMed] [Google Scholar]
  15. Garson J. A., Clewley J. P., Simmonds P., Zhang L. Q., Mori J., Ring C., Follett E. A., Dow B. C., Martin S., Gunson H. Hepatitis C viraemia in United Kingdom blood donors. A multicentre study. Vox Sang. 1992;62(4):218–223. doi: 10.1111/j.1423-0410.1992.tb01202.x. [DOI] [PubMed] [Google Scholar]
  16. Gish R. G., Lee A. H., Keeffe E. B., Rome H., Concepcion W., Esquivel C. O. Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol. 1993 Sep;88(9):1337–1342. [PubMed] [Google Scholar]
  17. Grant B. F., Harford T. C. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 1995 Oct;39(3):197–206. doi: 10.1016/0376-8716(95)01160-4. [DOI] [PubMed] [Google Scholar]
  18. Houben K. W., McCall J. L. Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. Liver Transpl Surg. 1999 Mar;5(2):91–95. doi: 10.1002/lt.500050201. [DOI] [PubMed] [Google Scholar]
  19. Iwatsuki S., Starzl T. E., Sheahan D. G., Yokoyama I., Demetris A. J., Todo S., Tzakis A. G., Van Thiel D. H., Carr B., Selby R. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991 Sep;214(3):221–229. doi: 10.1097/00000658-199109000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kiuchi T., Kasahara M., Uryuhara K., Inomata Y., Uemoto S., Asonuma K., Egawa H., Fujita S., Hayashi M., Tanaka K. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation. 1999 Jan 27;67(2):321–327. doi: 10.1097/00007890-199901270-00024. [DOI] [PubMed] [Google Scholar]
  21. Kumar S., Stauber R. E., Gavaler J. S., Basista M. H., Dindzans V. J., Schade R. R., Rabinovitz M., Tarter R. E., Gordon R., Starzl T. E. Orthotopic liver transplantation for alcoholic liver disease. Hepatology. 1990 Feb;11(2):159–164. doi: 10.1002/hep.1840110202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lee R. G. Recurrence of alcoholic liver disease after liver transplantation. Liver Transpl Surg. 1997 May;3(3):292–295. doi: 10.1002/lt.500030315. [DOI] [PubMed] [Google Scholar]
  23. Llovet J. M., Bruix J., Fuster J., Castells A., Garcia-Valdecasas J. C., Grande L., Franca A., Brú C., Navasa M., Ayuso M. C. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998 Jun;27(6):1572–1577. doi: 10.1002/hep.510270616. [DOI] [PubMed] [Google Scholar]
  24. Llovet J. M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999 Dec;30(6):1434–1440. doi: 10.1002/hep.510300629. [DOI] [PubMed] [Google Scholar]
  25. Loinaz C., Lumbreras C., González-Pinto I., Colina F., Gómez R., Fuertes A., Alvarado A., García I., Noriega A. R., Moreno E. High incidence of posttransplant hepatitis and chronic rejection associated with hepatitis C virus infection in liver transplant recipients. Transplant Proc. 1995 Feb;27(1):1217–1218. [PubMed] [Google Scholar]
  26. Louha M., Nicolet J., Zylberberg H., Sabile A., Vons C., Vona G., Poussin K., Tournebize M., Capron F., Pol S. Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology. 1999 Mar;29(3):879–882. doi: 10.1002/hep.510290348. [DOI] [PubMed] [Google Scholar]
  27. Maddrey W. C., Boitnott J. K., Bedine M. S., Weber F. L., Jr, Mezey E., White R. I., Jr Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978 Aug;75(2):193–199. [PubMed] [Google Scholar]
  28. Marcos A. Right-lobe living donor liver transplantation. Liver Transpl. 2000 Nov;6(6 Suppl 2):S59–S63. doi: 10.1053/jlts.2000.19011. [DOI] [PubMed] [Google Scholar]
  29. Marcos A. Split-liver transplantation for adult recipients. Liver Transpl. 2000 Nov;6(6):707–709. doi: 10.1053/jlts.2000.19028. [DOI] [PubMed] [Google Scholar]
  30. Merikangas K. R., Gelernter C. S. Comorbidity for alcoholism and depression. Psychiatr Clin North Am. 1990 Dec;13(4):613–632. [PubMed] [Google Scholar]
  31. Miwa S., Hashikura Y., Mita A., Kubota T., Chisuwa H., Nakazawa Y., Ikegami T., Terada M., Miyagawa S., Kawasaki S. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology. 1999 Dec;30(6):1521–1526. doi: 10.1002/hep.510300621. [DOI] [PubMed] [Google Scholar]
  32. Neuberger J., Adams D., MacMaster P., Maidment A., Speed M. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ. 1998 Jul 18;317(7152):172–175. doi: 10.1136/bmj.317.7152.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Neuberger J., James O. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet. 1999 Nov 6;354(9190):1636–1639. doi: 10.1016/S0140-6736(99)90002-8. [DOI] [PubMed] [Google Scholar]
  34. Neuberger J., Tang H. Relapse after transplantation: European studies. Liver Transpl Surg. 1997 May;3(3):275–279. doi: 10.1002/lt.500030313. [DOI] [PubMed] [Google Scholar]
  35. Otto G., Heuschen U., Hofmann W. J., Krumm G., Hinz U., Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 1998 Mar;227(3):424–432. doi: 10.1097/00000658-199803000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pereira S. P., Howard L. M., Muiesan P., Rela M., Heaton N., Williams R. Quality of life after liver transplantation for alcoholic liver disease. Liver Transpl. 2000 Nov;6(6):762–768. doi: 10.1053/jlts.2000.19030. [DOI] [PubMed] [Google Scholar]
  37. Pinna A. D., Iwatsuki S., Lee R. G., Todo S., Madariaga J. R., Marsh J. W., Casavilla A., Dvorchik I., Fung J. J., Starzl T. E. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997 Oct;26(4):877–883. doi: 10.1002/hep.510260412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Powell W. J., Jr, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med. 1968 Mar;44(3):406–420. doi: 10.1016/0002-9343(68)90111-3. [DOI] [PubMed] [Google Scholar]
  39. Poynard T., Marcellin P., Lee S. S., Niederau C., Minuk G. S., Ideo G., Bain V., Heathcote J., Zeuzem S., Trepo C. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet. 1998 Oct 31;352(9138):1426–1432. doi: 10.1016/s0140-6736(98)07124-4. [DOI] [PubMed] [Google Scholar]
  40. Read A. E., Donegan E., Lake J., Ferrell L., Galbraith C., Kuramoto I. K., Zeldis J. B., Ascher N. L., Roberts J., Wright T. L. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med. 1991 Feb 15;114(4):282–284. doi: 10.7326/0003-4819-114-4-282. [DOI] [PubMed] [Google Scholar]
  41. Reyes J., Gerber D., Mazariegos G. V., Casavilla A., Sindhi R., Bueno J., Madariaga J., Fung J. J. Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg. 2000 Feb;35(2):283–290. doi: 10.1016/s0022-3468(00)90026-5. [DOI] [PubMed] [Google Scholar]
  42. Ringe B., Pichlmayr R., Wittekind C., Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991 Mar-Apr;15(2):270–285. doi: 10.1007/BF01659064. [DOI] [PubMed] [Google Scholar]
  43. STRAUS R., BACON S. D. Alcoholism and social stability; a study of occupational integration in 2,023 male clinic patients. Q J Stud Alcohol. 1951 Jun;12(2):231–260. [PubMed] [Google Scholar]
  44. Shah G., Demetris A. J., Irish W., Scheffel J., Mimms L., Van Thiel D. H. Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test. J Hepatol. 1993 Jul;18(3):279–283. doi: 10.1016/s0168-8278(05)80270-3. [DOI] [PubMed] [Google Scholar]
  45. Shakil A. O., Pinna A., Demetris J., Lee R. G., Fung J. J., Rakela J. Survival and quality of life after liver transplantation for acute alcoholic hepatitis. Liver Transpl Surg. 1997 May;3(3):240–244. [PubMed] [Google Scholar]
  46. Shapiro R. S., Adams M. Ethical issues surrounding adult-to-adult living donor liver transplantation. Liver Transpl. 2000 Nov;6(6 Suppl 2):S77–S80. doi: 10.1053/jlts.2000.19014. [DOI] [PubMed] [Google Scholar]
  47. Sheiner P. A., Schluger L. K., Emre S., Thung S. N., Lau J. Y., Guy S. R., Schwartz M. E., Miller C. M. Retransplantation for recurrent hepatitis C. Liver Transpl Surg. 1997 Mar;3(2):130–136. doi: 10.1002/lt.500030205. [DOI] [PubMed] [Google Scholar]
  48. Starzl T. E., Groth C. G., Brettschneider L., Penn I., Fulginiti V. A., Moon J. B., Blanchard H., Martin A. J., Jr, Porter K. A. Orthotopic homotransplantation of the human liver. Ann Surg. 1968 Sep;168(3):392–415. doi: 10.1097/00000658-196809000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Takamori R., Wong L. L., Dang C., Wong L. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl. 2000 Jan;6(1):67–72. doi: 10.1002/lt.500060103. [DOI] [PubMed] [Google Scholar]
  50. Tan K. C., Rela M., Ryder S. D., Rizzi P. M., Karani J., Portmann B., Heaton N. D., Howard E. R., Williams R. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg. 1995 Feb;82(2):253–256. doi: 10.1002/bjs.1800820239. [DOI] [PubMed] [Google Scholar]
  51. Testa G., Crippin J. S., Netto G. J., Goldstein R. M., Jennings L. W., Brkic B. S., Brooks B. K., Levy M. F., Gonwa T. A., Klintmalm G. B. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl. 2000 Sep;6(5):553–561. doi: 10.1053/jlts.2000.9741. [DOI] [PubMed] [Google Scholar]
  52. Todo S., Furukawa H., Jin M. B., Shimamura T. Living donor liver transplantation in adults: outcome in Japan. Liver Transpl. 2000 Nov;6(6 Suppl 2):S66–S72. doi: 10.1053/jlts.2000.19009. [DOI] [PubMed] [Google Scholar]
  53. Totsuka E., Fung J. J., Urakami A., Moras N., Ishii T., Takahashi K., Narumi S., Hakamada K., Sasaki M. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology. 2000 Mar;31(3):577–580. doi: 10.1002/hep.510310305. [DOI] [PubMed] [Google Scholar]
  54. Trotter J. F., Wachs M., Trouillot T., Steinberg T., Bak T., Everson G. T., Kam I. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl. 2000 May;6(3):290–295. doi: 10.1002/lt.500060323. [DOI] [PubMed] [Google Scholar]
  55. Urena M. A., Moreno Gonzalez E., Romero C. J., Ruiz-Delgado F. C., Moreno Sanz C. An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterology. 1999 Mar-Apr;46(26):1164–1173. [PubMed] [Google Scholar]
  56. Weinrieb R. M., Van Horn D. H., McLellan A. T., Lucey M. R. Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery. Liver Transpl. 2000 Nov;6(6):769–776. doi: 10.1053/jlts.2000.18497. [DOI] [PubMed] [Google Scholar]
  57. Wright T. L., Donegan E., Hsu H. H., Ferrell L., Lake J. R., Kim M., Combs C., Fennessy S., Roberts J. P., Ascher N. L. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992 Jul;103(1):317–322. doi: 10.1016/0016-5085(92)91129-r. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES